Authors: Ennis, O Corcoran, A Kavanagh, K Mahon, BP Doyle, S

Citation: O. Ennis et al., Baculovirus expression of parvovirus B19 (B19V) NS1: utility in confirmingrecent infection, J CLIN VIRO, 22(1), 2001, pp. 55-60

Authors: Mahon, BP

Citation: Bp. Mahon, The rational design of vaccine adjuvants for mucosal and neonatal immunization, CURR MED CH, 8(9), 2001, pp. 1057-1075

Authors: Corcoran, A Doyle, S Waldron, D Nicholson, A Mahon, BP

Citation: A. Corcoran et al., Impaired gamma interferon responses against parvovirus B19 by recently infected children, J VIROLOGY, 74(21), 2000, pp. 9903-9910

Authors: Mahon, BP Brady, MT Mills, KHG

Citation: Bp. Mahon et al., Protection against Bordetella pertussis in mice in the absence of detectable circulating antibody: Implications for long-term immunity in children, J INFEC DIS, 181(6), 2000, pp. 2087-2091

Authors: Mahon, BP Mills, KHG

Citation: Bp. Mahon et Khg. Mills, Interferon-gamma mediated immune effector mechanisms against Bordetella pertussis, IMMUNOL LET, 68(2-3), 1999, pp. 213-217

Authors: Mahon, BP Moore, A Johnson, PA Mills, KHG

Citation: Bp. Mahon et al., Approaches to new vaccines, CR R BIOTEC, 18(4), 1998, pp. 257-282